Contribution of IL-33–activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice
暂无分享,去创建一个
Kenji Nakanishi | Shizuo Akira | Tatsukata Kawagoe | K. Ishii | S. Akira | H. Tsutsui | K. Nakanishi | M. Matsumoto | K. Matsushita | K. Yasuda | Ken J. Ishii | Makoto Matsumoto | Kazufumi Matsushita | Hiroko Tsutsui | Koubun Yasuda | Taichiro Muto | Yuki Sasaki | Yuko Taki | Shizue Futatsugi-Yumikura | Tomohiro Yoshimoto | T. Yoshimoto | S. Futatsugi-Yumikura | Y. Taki | T. Kawagoe | T. Muto | Y. Sasaki | Kazufumi Matsushita
[1] K. Austen,et al. Innate cells and T helper 2 cell immunity in airway inflammation. , 2009, Immunity.
[2] C. Dahinden,et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. , 2009, Blood.
[3] S. Orkin,et al. Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.
[4] S. Akira,et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. , 2007, Journal of leukocyte biology.
[5] T. Braciale,et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.
[6] 茂呂 和世. Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .
[7] R. Maizels,et al. Regulation of pathogenesis and immunity in helminth infections , 2009, The Journal of experimental medicine.
[8] S. Feldman,et al. Review of home phototherapy. , 2010, Dermatology online journal.
[9] T. Colby,et al. Knowns and unknowns of the alveolus. , 2008, Proceedings of the American Thoracic Society.
[10] C. Gabay,et al. Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage* , 2009, The Journal of Biological Chemistry.
[11] J. Fujimoto,et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. , 2008, International immunology.
[12] G. Krishna,et al. Parasitic pulmonary eosinophilia. , 2006, Seminars in respiratory and critical care medicine.
[13] H. Bovenschen,et al. Löffler syndrome caused by extensive cutaneous larva migrans: a case report and review of the literature. , 2010, Dermatology online journal.
[14] Ya-Jen Chang,et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.
[15] D. Pritchard,et al. Innate and cognate mechanisms of pulmonary eosinophilia in helminth infection , 2002, European journal of immunology.
[16] David J. Erle,et al. Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.
[17] H. Renz,et al. Immunomodulatory Effects of Viral TLR Ligands on Experimental Asthma Depend on the Additive Effects of IL-12 and IL-101 , 2007, The Journal of Immunology.
[18] Q. Hamid,et al. Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.
[19] S. Cullen,et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. , 2009, Immunity.
[20] K. Nakanishi. Basophils are potent antigen‐presenting cells that selectively induce Th2 cells , 2010, European journal of immunology.
[21] S. Koyasu,et al. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population , 2011, Current opinion in allergy and clinical immunology.
[22] A. McKenzie,et al. Elemental signals regulating eosinophil accumulation in the lung , 2001, Immunological reviews.
[23] R. Senior,et al. Characterization of mouse alveolar epithelial cell monolayers. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[24] J. Girard,et al. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.
[25] O. Mimura,et al. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. , 2010, International immunology.
[26] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[27] J. Kolls. Faculty Opinions recommendation of IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. , 2010 .
[28] T. Abe,et al. IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.
[29] S. Akira,et al. IL‐33 induces IL‐13 production by mouse mast cells independently of IgE‐FcεRI signals , 2007 .
[30] S. Akira,et al. The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function , 1999, The Journal of experimental medicine.
[31] H. Tsutsui,et al. Contribution of interleukin 18 to the development of infection-associated atopic dermatitis. , 2011, Current problems in dermatology.
[32] D. C. Cara,et al. Infection with Strongyloides venezuelensis Induces Transient Airway Eosinophilic Inflammation, an Increase in Immunoglobulin E, and Hyperresponsiveness in Rats , 2002, Infection and Immunity.
[33] D. Artis,et al. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. , 2010, Trends in immunology.
[34] T. Mcclanahan,et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. , 2011, International immunology.
[35] D. Voehringer,et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy , 2007, Nature.
[36] K. Nakanishi,et al. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity , 2005, The Journal of experimental medicine.
[37] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[38] D. Artis,et al. Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sites , 2008, Immunological reviews.
[39] A. McKenzie,et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.
[40] F. Finkelman,et al. Interleukin‐4‐ and interleukin‐13‐mediated host protection against intestinal nematode parasites , 2004, Immunological reviews.
[41] F. Liew,et al. IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes1 , 2008, The Journal of Immunology.
[42] James J. Lee,et al. Eosinophils Utilize Multiple Chemokine Receptors for Chemotaxis to the Parasitic Nematode Strongyloides stercoralis , 2009, Journal of Innate Immunity.
[43] E. S. Baekkevold,et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.
[44] W. Paul,et al. How are TH2-type immune responses initiated and amplified? , 2010, Nature Reviews Immunology.
[45] S. Free,et al. The structure and synthesis of the fungal cell wall , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[46] F. Liew,et al. IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation , 2010, The Journal of Immunology.